Huluwa Pharmaceutical (605119.SH) has released its 2022 annual report along with its Environmental, Social, and Governance (ESG) report. In 2022, Huluwa Pharmaceutical achieved a revenue of 1.515 billion yuan, marking an 11.91% year-on-year increase, while its net profit attributable to shareholders

Haikou, November 15, 2022 – At the Hainan Provincial Science and Technology Awards Conference, Huluwa Pharmaceutical Group was honored with the Second Prize of the Hainan Provincial Science and Technology Progress Award 2021 for its research project titled “Process Optimization of Xiao Er Fei Re Ke